---
title: "688373.SH (688373.SH) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/688373.SH/news.md"
symbol: "688373.SH"
name: "688373.SH"
parent: "https://longbridge.com/zh-HK/quote/688373.SH.md"
datetime: "2026-03-13T11:06:53.347Z"
locales:
  - [en](https://longbridge.com/en/quote/688373.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688373.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688373.SH/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/688373.SH/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/688373.SH/news.md)


# 688373.SH (688373.SH) — 相關新聞

### [MicuRx Pharmaceuticals performance report: The loss scale for the fiscal year 2025 has narrowed compared to the same period last year](https://longbridge.com/zh-HK/news/277025740.md)
*2026-02-26T10:53:03.000Z*
> MicuRx Pharmaceuticals released its performance preliminary report for 2025, with total operating revenue of 142 million

### [MicuRx: MRX-5 has obtained permission to conduct clinical trials in the United States](https://longbridge.com/zh-HK/news/273972800.md)
*2026-01-28T10:17:55.000Z*
> MicuRx Pharmaceuticals, Inc., a wholly-owned subsidiary of MicuRx, announced that it has received notification from the 

### [MicuRx: Shareholders plan to reduce their holdings by no more than 6% in total](https://longbridge.com/zh-HK/news/272537909.md)
*2026-01-14T10:43:46.000Z*
> MicuRx announced that shareholders BestIdea, JSR, and GPTMT plan to reduce their holdings of up to 19.6682 million share

### [MicuRx: Recognized as a high-tech enterprise, eligible for tax benefits](https://longbridge.com/zh-HK/news/272537426.md)
*2026-01-14T10:41:40.000Z*
> MicuRx announced that the company has been included in the "Second Batch of High-tech Enterprises Record List for 2025 R

### [MicuRx: Appointed Lu Liang as Deputy General Manager and Guo Cui as Financial Responsible Person](https://longbridge.com/zh-HK/news/272384949.md)
*2026-01-13T09:01:35.000Z*
> MicuRx announced that on January 12, 2026, the company's second board of directors held its twenty-fourth meeting and ap

### [MicuRx: Shareholder Best Idea International Limited's shareholding ratio has decreased to 7.91%](https://longbridge.com/zh-HK/news/271765103.md)
*2026-01-07T09:16:03.000Z*
> MicuRx announced that its shareholder Best Idea International Limited will reduce its holdings by 6.5561 million shares 

### [MicuRx: 79.5235 million shares of the initial public offering restricted shares will be listed and circulated on January 5, 2026](https://longbridge.com/zh-HK/news/270484836.md)
*2025-12-22T11:34:47.000Z*
> MicuRx announced that 79.5235 million shares of its initial public offering (IPO) restricted shares will be listed and c

### [MicuRx: Shareholder MicuRx Hong Kong reduced holdings by HKD 6.0801 million](https://longbridge.com/zh-HK/news/268588725.md)
*2025-12-04T11:23:31.000Z*
> MicuRx Pharmaceuticals announced that its shareholder MicuRx Limited reduced its holdings by 735,600 shares, accounting 

### [MicuRx's 1 billion yuan private placement plan has failed, which once triggered a control rights dispute](https://longbridge.com/zh-HK/news/267188887.md)
*2025-11-24T12:53:19.000Z*
> MicuRx's originally planned RMB 1.033 billion private placement scheme has been terminated due to opposition from major